The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Klacid LA 500 mg modified-release tablets

500 milligram(s) Modified-release tablet

PCO Manufacturing Ltd.PPA0465/051/004

Main Information

Trade NameKlacid LA 500 mg modified-release tablets
Active SubstancesClarithromycin
Strength500 milligram(s)
Dosage FormModified-release tablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/051/004

Group Information

ATC CodeJ01FA Macrolides
J01FA09 clarithromycin

Status

Authorised/WithdrawnAuthorised
Licence Issued18/07/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0072-117-050
Interchangeable List DocumentPDF of Interchangeable List
« Back